Our findings require validation in other cohorts and with a larger number of PR- breast cancer cases but suggest that a competition between ABSI-related factors such as glucocorticoids, sex steroids, and insulin resistance determines the net outcome for the risk of individual breast cancer subtypes. This evidence concerns the gene INS and breast carcinoma.